Search Results

Accenture has made a strategic investment, through Accenture Ventures, in Ocean Genomics, a technology and AI company that has developed advanced computational platforms to assist biopharma companies to discover and develop more effective diagnostics and therapeutics.

Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software.

Accenture (NYSE: ACN) today announced that it has built a data and analytics approach to manage and derive insights from pediatric acute myeloid leukemia (AML) genomic data.

Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use

Accenture (NYSE: ACN) and the Massachusetts Institute of Technology (MIT) are co-developing a supply chain resilience stress test for assessing operational and financial risks created by major market disruptions, disasters or other catastrophic events.

BioSymetrics , a biomedical artificial intelligence company that helps researchers develop drugs with greater speed and precision, announced it has joined Accenture’s partner ecosystem , designed to help independent software vendors (ISVs) and life science companies integrate more effectively to accelerate drug discovery efforts and

UCB Implements Accenture’s technology platform, INTIENT™ Pharmacovigilance

Takeda has entered into a five-year agreement with Accenture and Amazon Web Services (AWS) to support the Tokyo-based pharmaceutical company in moving 80% of its applications to the “cloud” and modernizing the company’s research tools.

Accenture (NYSE:ACN) and Google Cloud (NASDAQ:GOOG, GOOGL) today announced that Google Cloud will be the cloud technology provider for Accenture’s INTIENT™ life sciences industry platform.